Want to see SCND full AI Analyst Report?
Scientific Industries (SCND) Ratios
Scientific Industries Ratios
SCND's free cash flow for Q2 2026 was $-912.40K. For the 2026 fiscal year, SCND's free cash flow was decreased by $-8.30K and operating cash flow was $-904.10K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Jun 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.70 | 4.74 | 6.72 | 6.13 | 8.06 |
| Quick Ratio | 6.66 | 2.41 | 4.06 | 3.83 | 6.76 |
| Cash Ratio | 0.71 | 0.34 | 0.43 | 0.91 | 4.23 |
| Solvency Ratio | -0.31 | -2.33 | -2.93 | -2.25 | -1.03 |
| Operating Cash Flow Ratio | -6.04 | -2.11 | -3.35 | -2.69 | -1.44 |
| Short-Term Operating Cash Flow Coverage | -21.94 | -11.99 | -18.99 | 0.00 | -3.22 |
| Net Current Asset Value | $ 8.44M | $ 5.85M | $ 9.50M | $ 9.71M | $ 15.65M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.09 | 0.08 | 0.00 | 0.05 |
| Debt-to-Equity Ratio | 0.09 | 0.11 | 0.10 | 0.00 | 0.06 |
| Debt-to-Capital Ratio | 0.08 | 0.10 | 0.09 | 0.00 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.00 | 0.07 | 0.00 | 0.02 |
| Financial Leverage Ratio | 1.18 | 1.27 | 1.20 | 1.22 | 1.11 |
| Debt Service Coverage Ratio | -21.23 | -19.16 | -26.23 | 0.00 | -3.42 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.15 | 0.03 | 0.05 | 0.00 | 0.04 |
| Interest Debt Per Share | 0.09 | 0.10 | 0.13 | 0.00 | 0.22 |
| Net Debt to EBITDA | -0.00 | -0.07 | -0.06 | 0.26 | 1.84 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.78% | 44.19% | 45.92% | 44.26% | 50.90% |
| EBIT Margin | -150.35% | -61.97% | -83.34% | -78.00% | -48.17% |
| EBITDA Margin | -156.12% | -54.96% | -76.55% | -70.73% | -45.60% |
| Operating Profit Margin | -150.35% | -61.97% | -83.34% | -78.00% | -48.17% |
| Pretax Profit Margin | -35.14% | -60.17% | -81.81% | -77.76% | -41.48% |
| Net Profit Margin | -24.15% | -60.17% | -81.78% | -77.76% | -31.82% |
| Continuous Operations Profit Margin | -35.23% | -60.17% | -81.78% | 0.00% | -31.82% |
| Net Income Per EBT | 68.73% | 100.00% | 99.96% | 100.00% | 76.70% |
| EBT Per EBIT | 23.37% | 97.10% | 98.16% | 99.70% | 86.12% |
| Return on Assets (ROA) | -9.68% | -55.75% | -54.31% | -45.08% | -10.72% |
| Return on Equity (ROE) | -11.45% | -70.68% | -65.44% | -55.07% | -11.86% |
| Return on Capital Employed (ROCE) | -67.49% | -67.64% | -62.18% | -51.23% | -17.62% |
| Return on Invested Capital (ROIC) | -65.17% | -63.66% | -60.83% | -53.46% | -13.02% |
| Return on Tangible Assets | -9.85% | -60.28% | -59.14% | -50.31% | -14.10% |
| Earnings Yield | -19.21% | -68.18% | -37.47% | -21.15% | -9.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.38 | 8.39 | 8.43 | 7.98 | 6.00 |
| Payables Turnover | 8.35 | 10.20 | 8.44 | 6.58 | 10.58 |
| Inventory Turnover | 2.68 | 1.46 | 1.23 | 1.20 | 1.61 |
| Fixed Asset Turnover | 3.13 | 5.84 | 4.72 | 4.13 | 9.07 |
| Asset Turnover | 0.40 | 0.93 | 0.66 | 0.58 | 0.34 |
| Working Capital Turnover Ratio | 0.65 | 1.26 | 1.04 | 0.78 | 0.74 |
| Cash Conversion Cycle | 160.51 | 257.14 | 296.72 | 294.04 | 252.70 |
| Days of Sales Outstanding | 67.85 | 43.48 | 43.31 | 45.75 | 60.79 |
| Days of Inventory Outstanding | 136.37 | 249.43 | 296.63 | 303.76 | 226.39 |
| Days of Payables Outstanding | 43.70 | 35.78 | 43.23 | 55.46 | 34.49 |
| Operating Cycle | 204.21 | 292.91 | 339.95 | 349.50 | 287.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.72 | -0.35 | -0.61 | -0.81 | -0.50 |
| Free Cash Flow Per Share | -0.72 | -0.36 | -0.62 | -0.89 | -0.54 |
| Dividend Paid and CapEx Coverage Ratio | -128.95 | -37.24 | -46.74 | -11.26 | -6.23 |
| Capital Expenditure Coverage Ratio | -128.95 | -37.24 | -46.74 | -11.26 | -12.83 |
| Operating Cash Flow Coverage Ratio | -8.43 | -3.68 | -4.62 | 0.00 | -2.22 |
| Operating Cash Flow to Sales Ratio | -1.61 | -0.34 | -0.55 | -0.54 | -0.34 |
| Free Cash Flow Yield | -129.27% | -40.01% | -25.93% | -16.11% | -10.31% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.09 | -1.48 | -2.67 | -4.73 | -11.10 |
| Price-to-Sales (P/S) Ratio | 1.26 | 0.88 | 2.18 | 3.68 | 3.53 |
| Price-to-Book (P/B) Ratio | 0.60 | 1.04 | 1.75 | 2.60 | 1.32 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.77 | -2.50 | -3.86 | -6.21 | -9.70 |
| Price-to-Operating Cash Flow Ratio | -0.78 | -2.57 | -3.94 | -6.76 | -10.45 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | 0.05 | 0.12 | -0.03 | -0.10 |
| Enterprise Value Multiple | -0.81 | -1.68 | -2.91 | -4.94 | -5.91 |
| Enterprise Value | 6.36M | 9.87M | 24.78M | 36.59M | 26.33M |
| EV to EBITDA | -0.81 | -1.68 | -2.91 | -4.94 | -5.91 |
| EV to Sales | 1.26 | 0.92 | 2.23 | 3.49 | 2.69 |
| EV to Free Cash Flow | -0.77 | -2.61 | -3.94 | -5.90 | -7.40 |
| EV to Operating Cash Flow | -0.78 | -2.68 | -4.03 | -6.42 | -7.97 |
| Tangible Book Value Per Share | 0.92 | 0.79 | 1.23 | 1.84 | 2.90 |
| Shareholders’ Equity Per Share | 0.94 | 0.87 | 1.37 | 2.11 | 3.95 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.29 | 0.23 |
| Revenue Per Share | 0.45 | 1.02 | 1.10 | 1.50 | 1.47 |
| Net Income Per Share | -0.11 | -0.61 | -0.90 | -1.16 | -0.47 |
| Tax Burden | 0.69 | 1.00 | 1.00 | 1.00 | 0.77 |
| Interest Burden | 0.23 | 0.97 | 0.98 | 1.00 | 0.86 |
| Research & Development to Revenue | 0.49 | 0.27 | 0.32 | 0.27 | 0.17 |
| SG&A to Revenue | 1.27 | 0.79 | 0.49 | 0.51 | 0.41 |
| Stock-Based Compensation to Revenue | 0.10 | 0.11 | 0.20 | 0.24 | 0.22 |
| Income Quality | 6.68 | 0.57 | 0.68 | 0.70 | 0.90 |
Currency in USD
